References
- Sergi MJ, Rassovsky Y, Widmark C, et al. Social cognition in schizophrenia: relationships with neurocognition and negative symptoms. Schizophr Res. 2007;90(1–3):316–324. doi: 10.1016/j.schres.2006.09.028
- Green MJ, Phillips ML. Social threat perception and the evolution of paranoia. Neurosci Biobehav Rev. 2004;28(3):333–342. doi: 10.1016/j.neubiorev.2004.03.006
- Grady CL, Keightley ML. Studies of altered social cognition in neuropsychiatric disorders using functional neuroimaging. Can J Psychiatry. 2002;47(4):327–336. doi: 10.1177/070674370204700403
- Kucharska-Pietura K, Mortimer A. Can antipsychotics improve social cognition in patients with schizophrenia? CNS Drugs. 2013;27(5):335–343. doi: 10.1007/s40263-013-0047-0
- Hempel RJ, Dekker JA, van Beveren NJ, et al. The effect of antipsychotic medication on facial affect recognition in schizophrenia: a review. Psychiatry Res. 2010;178(1):1–9. doi: 10.1016/j.psychres.2008.07.025
- Bondolfi G, Dufour H, Patris M, et al. Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The risperidone study group. Am J Psychiatry. 1998;155(4):499–504. doi: 10.1176/ajp.155.4.499
- Fakra E, Salgado-Pineda P, Delaveau P, et al. Neural bases of different cognitive strategies for facial affect processing in schizophrenia. Schizophr Res. 2008;100(1–3):191–205. doi: 10.1016/j.schres.2007.11.040
- Ekman P, Friesen WV. Pictures of facial affect. Palo Alto: Consulting Psychologists; 1976.
- Hunter R, Barry S. Negative symptoms and psychosocial functioning in schizophrenia: neglected but important targets for treatment. Eur Psychiatry. 2012;27(6):432–436. doi: 10.1016/j.eurpsy.2011.02.015
- Mandal MK, Pandey R, Prasad AB. Facial expressions of emotions and schizophrenia: a review. Schizophr Bull. 1998;24(3):399–412. doi: 10.1093/oxfordjournals.schbul.a033335
- Kee KS, Horan WP, Mintz J, et al. Do the siblings of schizophrenia patients demonstrate affect perception deficits? Schizophr Res. 2004;67(1):87–94. doi: 10.1016/S0920-9964(03)00217-2
- Trémeau F. A review of emotion deficits in schizophrenia. Dialogues Clin Neurosci. 2006;8(1):59–70.
- Butler PD, Javitt DC. Early-stage visual processing deficits in schizophrenia. Curr Opin Psychiatry. 2005;18(2):151–157. doi: 10.1097/00001504-200503000-00008
- Addington J, Saeedi H, Addington D. Facial affect recognition: a mediator between cognitive and social functioning in psychosis? Schizophr Res. 2006;85(1–3):142–150. doi: 10.1016/j.schres.2006.03.028
- Woodward ND, Purdon SE, Meltzer HY, et al. A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. Int J Neuropsychopharmacol. 2005;8(3):457–472. doi: 10.1017/S146114570500516X
- Kucharska-Pietura K, Tylec A, Czernikiewicz A, et al. Attentional and emotional functioning in schizophrenia patients treated with conventional and atypical antipsychotic drugs. Med Sci Monit. 2012;18(1):CR44–CR49. doi: 10.12659/MSM.882202
- Harvey PD, Patterson TL, Potter LS, et al. Improvement in social competence with short-term atypical antipsychotic treatment: a randomized, double-blind comparison of quetiapine versus risperidone for social competence, social cognition, and neuropsychological functioning. Am J Psychiatry. 2006;163(11):1918–1925. doi: 10.1176/ajp.2006.163.11.1918
- Behere RV, Venkatasubramanian G, Arasappa R, et al. Effect of risperidone on emotion recognition deficits in antipsychotic-naïve schizophrenia: a short-term follow-up study. Schizophr Res. 2009;113(1):72–76. doi: 10.1016/j.schres.2009.05.026
- Williams LM, Das P, Liddell BJ, et al. Fronto-limbic and autonomic disjunctions to negative emotion distinguish schizophrenia subtypes. Psychiatry Res. 2007;155(1):29–44. doi: 10.1016/j.pscychresns.2006.12.018
- Machado de Sousa JP, Hallak JE. Neurocognitive functioning and facial affect recognition in treatment-resistant schizophrenia treated with clozapine. Schizophr Res. 2008;106(2–3):371–372. doi: 10.1016/j.schres.2008.09.012